TSX News -
Colliers International Group Inc. Completes US$300 Million Bought Deal Public Offering of Equity
TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) — Colliers International Group Inc. (TSX and NASDAQ: CIGI) (“Colliers” or the “Company”) is […]
Navigator Gas Announces Date for the Release of Fourth Quarter and Full Year 2023 Results and Zoom Conference Call
LONDON, Feb. 28, 2024 (GLOBE NEWSWIRE) — Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), […]
Regency Centers Upgraded by Moody’s to an ‘A3’ Credit Rating
JACKSONVILLE, Fla., Feb. 28, 2024 (GLOBE NEWSWIRE) — Regency Centers, L.P. (“Regency Centers”, the “Company” or “Regency”) announced today that […]
Stronghold Digital Mining Sets Fourth Quarter and Full Year 2023 Earnings Conference Call for Wednesday, March 6 at 11:00 a.m. Eastern Time
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) — Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Stronghold”, or the “Company”) will host […]
Applied Therapeutics Announces $100 Million Private Placement
Financing includes significant participation from a number of large healthcare dedicated institutional and mutual fund investors Net proceeds, along with […]
OrthoPediatrics Corp. Named One of the 2024 Best Places to Work in Indiana
WARSAW, Ind., Feb. 28, 2024 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively […]
Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying […]
iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings
Clinical evidence demonstrates ProFound Detection’s AI may help reduce breast interval cancer (IC) rates and decrease recall rates without additional […]
Nkarta to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural […]
Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference […]
